Invention Grant
- Patent Title: 2-heteroaryl substituted benzothiophenes and benzofuranes 709
- Patent Title (中): 2-杂芳基取代的苯并噻吩和苯并呋喃709
-
Application No.: US12042795Application Date: 2008-03-05
-
Publication No.: US07772256B2Publication Date: 2010-08-10
- Inventor: Erwan Arzel , Britt-Marie Swahn , David Wensbo
- Applicant: Erwan Arzel , Britt-Marie Swahn , David Wensbo
- Applicant Address: SE Sodertalje
- Assignee: Astrazeneca AB
- Current Assignee: Astrazeneca AB
- Current Assignee Address: SE Sodertalje
- Agent John A. Cleveland, Jr.
- Main IPC: A61K31/443
- IPC: A61K31/443 ; C07D405/04

Abstract:
The present invention relates to novel 2-heteroaryl substituted benzothiophene and benzofuran derivatives, precursors thereof, and therapeutic uses of such compounds, having the structural formula (Ia) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel 2-heteroaryl substituted benzothiophene and benzofuran derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.
Public/Granted literature
- US20080221149A1 Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709 Public/Granted day:2008-09-11
Information query
IPC分类: